Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address the Paradox of Choice

Hear from experts how the latest data from ASCO 2021 inform therapeutic strategies for patients with R/R MM and how to evaluate novel combination therapeutic regimens. Review their insights in clinical commentaries slides a podcast and an on-demand webcast from a live CCO webinar.

Share

Program Content

Activities

Paradox of Choice: Treatment for R/R MM
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address the Paradox of Choice
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2021

Expires: July 08, 2022

Activities

RR MM: After First Relapse
Managing Patients With MM After First Relapse: Current Treatment Options and Sequencing
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2021

Expires: June 22, 2022

RR MM: After Multiple Relapses
Treatment Options for Patients With Multiple Myeloma After Multiple Relapses
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 24, 2021

Expires: June 23, 2022

RR MM: Emerging Therapies
Emerging and Investigational Therapies for Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 24, 2021

Expires: June 23, 2022

<i>EP</i>: RR Myeloma Paradox of Choice
ExpressPoints
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma—Experts Address the Paradox of Choice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2021

Expires: June 24, 2022

Activities

Selecting Tx for R/R MM
The Paradox of Choice: Experts Address Critical Questions for Selecting and Sequencing Therapy for Patients With R/R MM
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 19, 2021

Expires: August 18, 2022

Activities

Myeloma Treatment Choices: FAQs
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2021

Expires: August 23, 2022

<i>Podcast Pearls</i>: R/R MM FAQs
Podcast Pearls
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2021

Expires: August 24, 2022

Faculty

cover img faculity

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Nina Shah, MD

Professor of Clinical Medicine
Division of Hematology-Oncology
Department of Medicine
University of California, San Francisco
San Francisco, California

cover img faculity

Peter Michael Voorhees, MD

Assistant Professor of Medicine
Department of Hematology/Oncology
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

GlaxoSmithKline

Karyopharm

Oncopeptides

Sanofi Genzyme